Seongnam-si, South Korea

Mi Young Cha

This inventor holds 1 USPTO granted patent. Top assignee: Genome and Company. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mi Young Cha. Retrieved from https://idiyas.com/inventor/mi-young-cha-4eg2dhiv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mi Young Cha: Innovator in Anti-Cancer Research

Introduction

Mi Young Cha is a prominent inventor based in Seongnam-si, South Korea. She has made significant contributions to the field of cancer research, particularly in developing novel therapeutic targets. Her work is crucial in the ongoing battle against cancer and enhancing immune responses.

Latest Patents

Mi Young Cha holds a patent for a "Novel Target for Anti-Cancer and Immune-Enhancing." This innovative approach aims to provide new avenues for cancer treatment and improve patient outcomes. The patent reflects her dedication to advancing medical science and finding effective solutions for complex health issues. She has 1 patent to her name.

Career Highlights

Cha is currently employed at Genome and Company, where she collaborates with a team of experts to push the boundaries of genetic research and therapeutic development. Her role at the company allows her to apply her knowledge and skills in a practical setting, contributing to groundbreaking advancements in healthcare.

Collaborations

One of her notable collaborators is Bu-Nam Jeon, who works alongside her at Genome and Company. Together, they strive to innovate and enhance the effectiveness of cancer treatments through their research.

Conclusion

Mi Young Cha is a dedicated inventor whose work in anti-cancer research is paving the way for new therapeutic strategies. Her contributions are vital in the fight against cancer, and her innovative spirit continues to inspire others in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…